-
1 Comment
Ningbo David Medical Device Co., Ltd is currently in a long term downtrend where the price is trading 11.4% below its 200 day moving average.
From a valuation standpoint, the stock is 9.0% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 10.5.
Ningbo David Medical Device Co., Ltd's total revenue rose by 19.3% to $143M since the same quarter in the previous year.
Its net income has dropped by 55.7% to $10M since the same quarter in the previous year.
Finally, its free cash flow grew by 41.4% to $109M since the same quarter in the previous year.
Based on the above factors, Ningbo David Medical Device Co., Ltd gets an overall score of 2/5.
| Sector | Healthcare |
|---|---|
| Industry | Medical Devices |
| Exchange | SHE |
| CurrencyCode | CNY |
| ISIN | CNE100001DD1 |
| Target Price | None |
|---|---|
| Beta | 0.27 |
| Market Cap | 3B |
| PE Ratio | 58.95 |
| Dividend Yield | 1.5% |
Ningbo David Medical Device Co., Ltd. engages in the research and development, production, and distribution of medical equipment worldwide. The company provides infant incubators, transport incubators, infant radiant warmers, neonate bilirubin phototherapy equipment, infant resuscitators, etc. It also offers other products, such as infusion pumps, transcutaneous jaundice detectors, infant t-piece resuscitators, air/oxygen blenders, low pressure aspirators, and infant oxygen hoods. The company offers its products under David brand name. Ningbo David Medical Device Co., Ltd. was founded in 1992 and is headquartered in Ningbo, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300314.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
